CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers. It offers personalized medicine, immunotherapies, cellular therapies, CAR T-cell therapies, stem cell therapies, cell lines, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, bio-pharmaceuticals, infectious substances, and other commodities that require continuous exposure to certain ranges of precision-controlled temperatures. The company was founded on May 25, 1990 and is headquartered in Irvine, CA.
Industry, Sector and Symbol
Industry Freight transportation arrangement
Sub-IndustryN/A
SectorTransportation
Phone949-470-2300
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$19.63 million
Profitability
Miscellaneous
EmployeesN/A
Next Earnings Date8/8/2019 (Estimated)
OptionableOptionable
CryoPort (NASDAQ:CYRX) Frequently Asked Questions
What is CryoPort's stock symbol?
CryoPort trades on the NASDAQ under the ticker symbol "CYRX."
How were CryoPort's earnings last quarter?
CryoPort Inc (NASDAQ:CYRX) issued its quarterly earnings results on Thursday, May, 2nd. The consumer goods maker reported ($0.08) earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of ($0.08). The consumer goods maker earned $6.65 million during the quarter, compared to analyst estimates of $6.56 million. CryoPort had a negative net margin of 41.61% and a negative return on equity of 28.30%. The business's revenue was up 65.4% compared to the same quarter last year. During the same quarter in the previous year, the firm earned ($0.10) earnings per share. View CryoPort's Earnings History.
When is CryoPort's next earnings date?
What price target have analysts set for CYRX?
4 analysts have issued 12 month price targets for CryoPort's stock. Their forecasts range from $16.00 to $22.00. On average, they anticipate CryoPort's share price to reach $19.75 in the next year. This suggests a possible upside of 16.0% from the stock's current price. View Analyst Price Targets for CryoPort.
What is the consensus analysts' recommendation for CryoPort?
4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CryoPort in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for CryoPort.
Has CryoPort been receiving favorable news coverage?
News stories about CYRX stock have been trending somewhat negative recently, InfoTrie reports. The research firm rates the sentiment of news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. CryoPort earned a coverage optimism score of -1.1 on InfoTrie's scale. They also gave press coverage about the consumer goods maker a news buzz of 5.0 out of 10, indicating that recent news coverage is somewhat likely to have an impact on the company's share price in the immediate future.
Who are some of CryoPort's key competitors?
What other stocks do shareholders of CryoPort own?
Who are CryoPort's key executives?
CryoPort's management team includes the folowing people:
- Jerrell W. Shelton, Chairman, President & Chief Executive Officer
- Phil Wilson, SVP-Global Operations & Supply Chain
- Robert S. Stefanovich, Chief Financial Officer, Secretary & Treasurer
- Bret Bollinger, Chief Technology Officer
- Mark W. Sawicki, Chief Commercial Officer
Who are CryoPort's major shareholders?
CryoPort's stock is owned by many different of retail and institutional investors. Top institutional investors include BlackRock Inc. (6.24%), Creative Planning (1.95%), Pier Capital LLC (1.65%), OppenheimerFunds Inc. (1.54%), FMR LLC (1.28%) and Geode Capital Management LLC (1.20%). Company insiders that own CryoPort stock include Jerrell Shelton and Richard J Berman. View Institutional Ownership Trends for CryoPort.
Which institutional investors are selling CryoPort stock?
CYRX stock was sold by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., Morgan Stanley, Wells Fargo & Company MN, FMR LLC, Creative Planning, Rice Hall James & Associates LLC, Essex Investment Management Co. LLC and BerganKDV Wealth Management LLC. Company insiders that have sold CryoPort company stock in the last year include Jerrell Shelton and Richard J Berman. View Insider Buying and Selling for CryoPort.
Which institutional investors are buying CryoPort stock?
CYRX stock was bought by a variety of institutional investors in the last quarter, including Pier Capital LLC, BlackRock Inc., Roubaix Capital LLC, Geode Capital Management LLC, Victory Capital Management Inc., Taylor Frigon Capital Management LLC, Penn Capital Management Co. Inc. and Penn Capital Management Co. Inc.. View Insider Buying and Selling for CryoPort.
How do I buy shares of CryoPort?
Shares of CYRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is CryoPort's stock price today?
One share of CYRX stock can currently be purchased for approximately $17.02.
How big of a company is CryoPort?
CryoPort has a market capitalization of $522.17 million and generates $19.63 million in revenue each year. The consumer goods maker earns $-9,560,000.00 in net income (profit) each year or ($0.31) on an earnings per share basis.
What is CryoPort's official website?
How can I contact CryoPort?
CryoPort's mailing address is 17305 DAIMLER STREET, IRVINE CA, 92614. The consumer goods maker can be reached via phone at 949-470-2300 or via email at [email protected]
MarketBeat Community Rating for CryoPort (NASDAQ CYRX)
MarketBeat's community ratings are surveys of what our community members think about CryoPort and other stocks. Vote "Outperform" if you believe CYRX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CYRX will underperform the S&P 500 over the long term. You may vote once every thirty days.
